الفهرس 
AbstractOnly 14 pages are availabe for public view
 |  | from | 138 |  |  |
| | | from | 138 | | |
Abstract
Summary
In December 2019, an unknown cause of pneumonia was identified in Wuhan (Hubei, China), and was called the acute respiratory syndrome coronavirus 2 (causing the disease COVID-19). The COVID-19, as the sixth public health emergency of international concern, has been rapidly spread from its origin throughout the world.
The symptoms of COVID-19 range from mild to severe. Not only does it affect the respiratory system, but clinical studies suggest multisystem involvement of COVID-19 including neurological, gastrointestinal, and ophthalmological systems. Its impact on sexual performance is understudied.
This study was conducted at Beni-Suef University Hospital on married sexually active females 20 – 40 years old after convalescence from coronavirus to evaluate the effect of COVID-19 on female sexual function and to determine if this effect is stationary or regressive. The mean age of the studied females was 31.8±4, it was ranged from 23 to 40 years.
After 1 month of getting infected with COVID 19 about 52% of the participant had sexual dysfunction with a mean total FSFI score 25.7±4.4. After 2 months the percent of participants with female sexual dysfunction decreased to 36 % with a mean total FSFI score 27.4±2.7. By the end of the 3rd month the percent of participants with female sexual dysfunction decreased to 34 % with a mean total FSFI score 27.6±2.4. There was a significant increase of FSFI score from 1 month after COVID 19 till 3 months, but the increase was more between 1 and 2 months than from 2 to 3 months.
Regarding the assessment of depression using the Beck Depression Inventory score, the study showed that after 1 month of getting infected with COVID 19 the mean Beck Depression Inventory score of the affected females was 13.1±4.3. After 2 months the mean Beck Depression Inventory score decreased to 10.2±2.5. By the end of the 3rd month the mean Beck Depression Inventory score reached 9.9±2.2. There was a significant decrease of BDI from 1 month after COVID 19 till 3 months, but the decrease was more between 1 and 2 months than from 2 to 3 months. Also, there was a significant negative linear correlation between the total FSFI score and the mean Beck Depression Inventory score.
Our study also showed that the mean SF-36 for Quality of Life after 1 month of COVID infection was 41.28±6.27 and after 2 months it reached 41.86±5. By the end of the 3rd month the mean SF-36 for Quality of Life was 42.74±5.5. The mean SF-36 for Quality of Life indicates a worse state among the studied participants. There was no significant change in the quality of life according to the SF-36 score during the 1st 3 months after COVID 19 infection. There was a significant linear positive correlation between the SF-36 and the total FSFI score. Also, there was a significant lower SF-36 scoreafter 1, 2, and 3 months in patients with sexual dysfunction than patients without sexual dysfunction.
In conclusion,COVID 19 infection has a negative effect on female sexual function and quality of life. This sexual dysfunction is more after one month of infection with mild depression of the affected females. The condition is regressive with marked improvement after two months.